EDR Peptide (Pinealon) in Neuroprotection: Oxidative Stress Reduction and Anti-Apoptotic Mechanisms in Neural Tissue
Abstract
A structured review of the published Khavinson bioregulation literature on the tripeptide EDR (Pinealon), focusing on its reported neuroprotective mechanisms: reactive oxygen species suppression, caspase-3 modulation, and dendritic spine morphology restoration in preclinical models of hypoxia and neurodegeneration. RGC relevance is contextualized as a CNS-neuron neuroprotection target. Reference survey only; no clinical outcome is asserted.
Methods
- 01Scope : EDR neuroprotective mechanisms in neural tissue
- 02Sources : Khavinson group primary studies, cell models, animal models
- 03Extraction : ROS reduction, caspase-3 modulation, dendritic morphology
- 04Framing : neutral synthesis, no meta-analysis of human endpoints
DISCLOSURE : This report presents anonymized in-silico and/or observational reference data. It does not establish a causal relationship between any catalogued material and any physiological outcome, and it is not a claim of safety, efficacy, or benefit.
Compounds referenced
This note surveys published work on the following compound. They are research materials, not treatments, and nothing here indicates they are suitable for any use in humans.